Curated News
By: NewsRamp Editorial Staff
April 11, 2025
Creative Biolabs Expands Bacteroides Platform for Probiotic Development
TLDR
- Clients gain competitive advantage by utilizing Bacteroides strains for probiotic development with enhanced immune modulation and metabolic regulation capabilities.
- Creative Biolabs uses anaerobic cultivation techniques for isolating and identifying Bacteroides strains through 16S rRNA sequencing, whole-genome sequencing, and mass spectrometry.
- The Bacteroides platform at Creative Biolabs offers potential interventions for metabolic disorders, inflammatory bowel diseases, and neurological conditions, improving overall health outcomes.
- Creative Biolabs provides multi-dimensional assessment services for Bacteroides strains, including SCFA production, adhesion to intestinal cells, and metabolic biomarker testing.
Impact - Why it Matters
This news highlights the growing importance of microbiome research and the potential of Bacteroides in addressing various health conditions. Creative Biolabs' advancements in strain development and production services offer valuable resources for researchers and could lead to new probiotic solutions for metabolic disorders and inflammatory conditions.
Summary
Microbiome research is focusing on the genus Bacteroides for its potential in metabolic disorders and immune system interaction. Creative Biolabs broadens its Bacteroides platform for probiotic development, including strain capture and in vitro assessments. The company offers laboratory-scale production services for Bacteroides strains, optimizing anaerobic fermentation and quality control.
Source Statement
This curated news summary relied on this press release disributed by 24-7 Press Release. Read the source press release here, Creative Biolabs Expands Bacteroides Platform for Probiotic Development
